System and method for in vitro blood vessel modeling

Patent metadata

Field	Value
Publication number	US-9595206-B2
Application number	US-86696809-A
Country	US
Kind code	B2
Filing date	Feb 11, 2009
Priority date	Feb 11, 2008
Publication date	Mar 14, 2017
Grant date	Mar 14, 2017

Abstract

The present invention provides an in vitro blood vessel model for investigation of drug induced vascular injury and other vascular pathologies. The in vitro blood vessel model provides two channels separated by a porous membrane that is coated on one side by an endothelial cell layer and is coated on the other side by a smooth muscle cell layer, wherein said model is susceptible to the extravasation of red blood cells across said porous membrane due to drug induced vascular injury.

First claim

What is claimed is:

1. An in vitro blood vessel model comprising two elongated channels separated by a porous membrane coated on one side by an endothelial cell layer and coated on the other side by a smooth muscle cell layer, wherein the model is susceptible to the extravasation of red blood cells across the porous membrane due to drug induced vascular injury, wherein one of the channels has: a bottom formed by the porous membrane coated with the smooth muscle cell layer of the porous membrane; opposing sidewalls extending from the bottom; and a top that is open along a length of the channel.

2. The in vitro blood vessel model of claim 1 wherein the porous membrane has pore sizes ranging from approximately 0.1 to 30 μm and a porosity between approximately 5 and 50 percent.

3. The in vitro blood vessel model of claim 2 wherein said porous membrane has an 11 percent porosity, pore sizes ranging from 2.3 to 13 μm, and an average pore size of 6.4 μm.

4. The in vitro blood vessel model of claim 3 wherein said porous membrane is a track-etched polycarbonate membrane.

5. The in vitro blood vessel model of claim 4 wherein said porous membrane is coated with at least one of elastin, fibrin, fibronectin, laminin, hyaluronic acid, and collagen.

6. The in vitro blood vessel model of claim 1 wherein said two channels are a luminal channel and an open smooth muscle channel, wherein the open smooth muscle channel includes opposing beveled walls adjacent to the porous membrane.

7. The in vitro blood vessel model of claim 6 wherein at least one of the luminal channel and the smooth muscle channel includes at least one bifurcation.

8. The in vitro blood vessel model of claim 6 wherein said open smooth muscle channel is capped with a lid to seal the smooth muscle channel from an external atmosphere.

9. The in vitro blood vessel model of claim 1 wherein said two channels include offset inflow and outflow ponds that reduce non-physiological shear stress on the porous membrane.

10. The in vitro blood vessel model of claim 1 wherein fibroblasts are seeded on the smooth muscle cell layer to replicate an adventitial layer.

11. The in vitro blood vessel model of claim 1 wherein adipocytes are seeded on the smooth muscle cell layer to create perivascular fat tissue.

12. The in vitro blood vessel model of claim 6 wherein the porous membrane is remodeled by smooth muscle and endothelial cells over time to produce a membrane containing physiologic proteins that allows the extravasation under appropriate conditions.

13. An in vitro model of a small diameter blood vessel comprising:
a bottom layer defining a luminal channel;
a top layer defining an open top smooth muscle channel so that when the open top smooth muscle channel contains a fluid, the fluid is exposed to air;
a porous membrane sandwiched between the top layer and bottom layer to separate the channels, the porous membrane having: a bottom side facing the luminal channel and being coated by an endothelial cell layer; and a top side facing the open top smooth muscle channel and being coated by a smooth muscle cell layer,
wherein the porous membrane approximates an internal elastic lamina of blood vessels.

14. The model of claim 13 , wherein the porous membrane is a track-etched polycarbonate membrane coated with at least one of elastin, fibronectin, fibrin, laminin, hyalauric acid, and collagen.

15. The model of claim 13 , further comprising fibroblasts seeded above the smooth muscle cell layer.

16. The model of claim 13 , wherein the open top smooth muscle channel is defined by opposing sidewalls in the top layer, enclosed on a bottom side by the porous membrane, open on a top side, and the opposing sidewalls are beveled towards the porous membrane.

17. The model of claim 13 , wherein the bottom layer defines a first flow area pond in fluid communication with the luminal channel and the top layer defines a second flow area pond in fluid communication with the open top smooth muscle channel.

18. The model of claim 17 , wherein: the ponds are offset with respect to each other and the open top smooth muscle channel has a larger volume as compared to the luminal channel.

19. The model of claim 13 , wherein the luminal channel is bifurcated to form an access port and further comprising a fitting coupled to the access port.

20. An in vitro model of a small diameter blood vessel comprising:
a bottom layer defining a luminal channel;
a top layer defining a smooth muscle channel so that when the smooth muscle channel contains a fluid, the fluid is exposed to air, wherein a volume of the smooth muscle channel is relatively larger than a volume of the luminal channel;
a porous membrane sandwiched between the top layer and bottom layer to separate the channels, the porous membrane having a bottom side facing the luminal channel and being coated by an endothelial cell layer and coated on a top side facing the smooth muscle channel by a smooth muscle cell layer, wherein the porous membrane approximates an internal elastic lamina of blood vessels,
wherein the smooth muscle channel has a bottom extending between opposing sidewalls and an open top.

21. The model of claim 18 , wherein the luminal channel and the open top smooth muscle channel are elongated and centrally aligned with the open top smooth muscle channel having a larger volume as compared to the luminal channel.

22. The in vitro blood vessel model of claim 20 wherein the open top is open along an entire length of the smooth muscle channel.

Assignees

• Hoganson David M
• Vacanti Joseph P
• Borenstein Jeffrey T
• The General Hospital
• Charles Stark Draper Laboratory Inc

Inventors

• Hoganson David M
• Vacanti Joseph P
• Borenstein Jeffrey T

Classifications

• C12M23/34

  Internal compartments or partitions · CPC title

• C12M25/02

  Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

• G09B23/28 Primary

  for medicine · CPC title

• B01L3/5027

  by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip · CPC title

• A61L27/18 Primary

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title